Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Super-rep: working with the new NHS

June 20, 2007 Sales and Marketing NHS, sales, strategy

Every year could be called a watershed year for the NHS – it seems that constant change and reinvention is …
Feature

Latest news from Datamonitor

June 19, 2007 Sales and Marketing

Lilly launches research effort to fight TBEli Lilly has announced the creation of a public-private partnership to conduct early-phase discovery …
News

NICE set to block blindness drugs

June 15, 2007 Sales and Marketing AMD, Lucentis, Macugen, NICE

Most patients in England and Wales will be denied access to drugs for the leading cause of sight loss if …
News

Generic firm Dr Reddy’s opens its first European R&D base

June 15, 2007 Sales and Marketing

Dr Reddy's Laboratories plans to become an R&D-based company are picking up pace with the opening of its first European …
News

FDA committee scotches Acomplia’s prospects

June 15, 2007 Sales and Marketing

The future of Sanofi-Aventis' potential blockbuster Acomplia has been dealt a serious blow after an influential committee of FDA advisers …
News

Moore’s Sicko stirs controversy

June 13, 2007 Sales and Marketing

Michael Moore's latest film opens at cinemas this month and has predictably raised passions with its critical dissection of the …
News

Avandia scare casts doubt over its future for Alzheimer’s

June 13, 2007 Sales and Marketing Avandia, diabetes, safety

 New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …
News

ProStrakan begins pan-European launch campaign with Tostran

June 11, 2007 Sales and Marketing

ProStrakan has unveiled Tostran in the UK, the first in a pan-European programme of product launches.Tostran is a testosterone replacement …
News

Latest news from Datamonitor

June 8, 2007 Research and Development, Sales and Marketing

Accorda enrols first patient in phase III MS studyAcorda Therapeutics has begun a second phase III clinical study of Fampridine-SR …
News

Amgen boosts pipeline with spending spree

June 7, 2007 Research and Development, Sales and Marketing

Amgen has spent $720 million acquiring two US biotech companies in deals that add potential treatments for diabetes and kidney …
News

BMS launches next generation arthritis treatment Orencia

June 6, 2007 Sales and Marketing

Bristol-Myers Squibb has launched its next generation rheumatoid arthritis treatment Orencia in the UK, offering patients a novel way of …
News

Bavarian Nordic secures $1.6 billion deal with US government

June 6, 2007 Sales and Marketing

Danish company Bavarian Nordic has secured a massive new contract to provide the US with millions of doses of smallpox …
News

Product roundup from Datamonitor

June 4, 2007 Sales and Marketing

Celsion completes enrolment in phase I liver cancer studyCelsion has completed its phase I dose escalation study, using ThermoDox, to …
News

China’s former medicines regulator sentenced to death

May 31, 2007 Sales and Marketing

The former head of China's medicines regulator has been sentenced to death after being found guilty of taking bribes to …
News

Avandia safety concerns hit GSK shares

May 31, 2007 Sales and Marketing

Shares in GSK have taken another hit after news that US prescribers have turned away from diabetes drug Avandia in …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026